Q&A: Why people at increased risk of thrombosis are safe to get the AstraZeneca vaccine

Rare blood clots linked to the vaccine 'are a different entity'

Six Australians have now developed thrombosis with thrombocytopenia syndrome (TTS), the rare disorder associated with AstraZeneca’s COVID-19 vaccine.

Professor Huyen Tran
Professor Huyen Tran.

Incorrect perceptions about risk are fuelling hesitancy among patients who have an increased risk or personal history of clots.

Antony Scholefield spoke with leading haematologist